Glaucoma Insights

Sight Sciences announces first patient treated in TRIDENT European trial

Novel trial design will compare safety and effectiveness outcomes for the OMNI Surgical System and the iStent inject in lowering IOP as a standalone treatment option without concomitant cataract surgery.

Understanding what is behind the trabecular meshwork

A complete understanding can help ophthalmologists get better results for their patients.

Study: Minorities with glaucoma facing cost barriers to medication

In advance of World Glaucoma Week March 6-12, a study of 3826 patients with glaucoma has found significantly higher odds of self-reported difficulty affording medication observed among non-Hispanic African American and Hispanic individuals compared with non-Hispanic White individuals.